Feilding-Mellen Cosmo
Transaction: 11/25/2025
SELL
Change
-40,400
Price
$4.48
Filing
11/26/2025
Type
SELL
Atai Beckley Inc.
ATAI • Biotechnology
$7.39
▲ +0.05 (+0.68%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.67B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 11.74Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:49 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.39
Change0.68%
Shares Out360.75M
Market Cap$2.67B
Enterprise Value$2.44B
52W Range3.27 - 7.26
Beta1.55
P/E-3.99
P/S596.01
P/B15.12
P/FCF-19.96
EV/Sales546.07
Price$7.39
Change0.68%
Shares Out360.75M
Market Cap$2.67B
Enterprise Value$2.44B
52W Range3.27 - 7.26
Beta1.55
P/E-3.99
P/S596.01
P/B15.12
P/FCF-19.96
EV/Sales546.07
EV/EBITDA-16.75
EV/FCF-18.29
Earnings Yield-25.06%
FCF Yield-5.01%
Dividend Yield0.00%
Gross Margin75.25%
Oper. Margin-24.40%
Profit Margin-161.42%
Debt/Eq0.01
Current Ratio11.74
Quick Ratio11.74
Target$7.69
Target Upside4.06%
Target Median$7.50
Target Range7.45 - 8.00
Volume4.06M
Avg Volume10.10M
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 11.74Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
50/100
Neutral
Bullish
0
Hold
8
Bearish
0
Price Target
2026-08-14
Low
$7.45
Mean
$7.69
Median
$7.50
High
$8.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Feilding-Mellen Cosmo
Transaction: 11/05/2025
OTHER
Change
0
Price
Not reported
Filing
11/06/2025
Type
OTHER
HERSHBERG ROBERT
Transaction: 11/05/2025
OTHER
Change
0
Price
Not reported
Filing
11/06/2025
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Feilding-Mellen Cosmo | SELL | -40,400 | $4.48 | 11/25/2025 | 11/26/2025 |
| Feilding-Mellen Cosmo | OTHER | 0 | Not reported | 11/05/2025 | 11/06/2025 |
| HERSHBERG ROBERT | OTHER | 0 | Not reported | 11/05/2025 | 11/06/2025 |
| Feilding-Mellen Cosmo | BUY | +40,400 | $4.48 | 11/05/2025 | 11/06/2025 |
| Feilding-Mellen Cosmo | BUY | +7,702,990 | Not reported | 11/05/2025 | 11/06/2025 |
| HERSHBERG ROBERT | BUY | +62,394 | $1.35 | 11/05/2025 | 11/06/2025 |
| Braunstein Scott | BUY | +56,818 | $5.28 | 11/04/2025 | 11/06/2025 |
| Barrett Christopher Ryan Cave | OTHER | 0 | Not reported | 10/01/2025 | 10/03/2025 |
| Barrett Christopher Ryan Cave | OTHER | +71,620 | $2.86 | 10/01/2025 | 10/03/2025 |
| Apeiron Investment Group Ltd. | SELL | -147,950 | Not reported | 09/30/2025 | 10/02/2025 |
| Apeiron Investment Group Ltd. | BUY | +2,367,200 | Not reported | 09/30/2025 | 10/02/2025 |
| Apeiron Investment Group Ltd. | BUY | +8,675,799 | $2.19 | 08/14/2025 | 08/18/2025 |
| Rao Srinivas | BUY | +217,777 | $2.50 | 08/13/2025 | 08/15/2025 |
| Angermayer Christian | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| Braunstein Scott | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| Fischer Laurent | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| Hoffman John Francis | BUY | +206,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| JOHNSON SABRINA MARTUCCI | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| Kalali Amir H | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |
| Smiley Andrea Heslin | BUY | +103,000 | $2.25 | 06/26/2025 | 06/27/2025 |